These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 4144533)
1. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Riis P; Anthonisen P; Wulff HR; Folkenborg O; Bonnevie O; Binder V Scand J Gastroenterol; 1973; 8(1):71-4. PubMed ID: 4144533 [No Abstract] [Full Text] [Related]
2. [The prophylactic effect of salazosulfapyridine in ulcerative colitis after a period of one year without symptoms on long-term treatment. A double-blind investigation]. Binder V; Bonnevie O; Folkenborg O; Anthonisen P; Wulff HR; Riis P Ugeskr Laeger; 1972 Oct; 134(40):2093-5. PubMed ID: 4405794 [No Abstract] [Full Text] [Related]
3. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer. Davies PS; Rhodes J; Counsell B; Evans BK Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711 [TBL] [Abstract][Full Text] [Related]
5. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis. Kruis W; Judmaier G; Kayasseh L; Stolte M; Theuer D; Scheurlen C; Hentschel E; Kratochvil P Eur J Gastroenterol Hepatol; 1995 May; 7(5):391-6. PubMed ID: 7614099 [TBL] [Abstract][Full Text] [Related]
6. The therapeutic effect of methyl-salazosulphapyridine versus salazosulphapyridine in active ulcerative colitis. A double-blind controlled trial. Riis P; Jarnum S; Holtz A; Folkenborg O; Kristensen M; Binder V Scand J Gastroenterol; 1979; 14(6):647-51. PubMed ID: 43585 [TBL] [Abstract][Full Text] [Related]
7. The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study. Anthonisen P; Barany F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H Scand J Gastroenterol; 1974; 9(6):549-54. PubMed ID: 4153646 [No Abstract] [Full Text] [Related]
9. The relapse-preventing effect of methyl-salazosulphapyridine compared to salazosulphapyridine during long-term treatment of ulcerative colitis. A double-blind controlled trial. Riis P; Binder V; Kristensen M; Folkenborg O; Holtz A; Jarnum S Scand J Gastroenterol; 1979; 14(3):257-60. PubMed ID: 35824 [TBL] [Abstract][Full Text] [Related]
10. [Rectal effect of salazopyrine in ulcerative colitis during a double-blind study]. Schulz U; Hanke P; Seige K Wien Z Inn Med; 1973; 54(4):185-9. PubMed ID: 4148682 [No Abstract] [Full Text] [Related]
12. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Baker DE; Kane S Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719 [TBL] [Abstract][Full Text] [Related]
13. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial. Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903 [TBL] [Abstract][Full Text] [Related]
14. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial. Wenckert A; Kristensen M; Eklund AE; Barany F; Jarnum S; Worning H; Folkenborg O; Holtz A; Bonnevie O; Riis P Scand J Gastroenterol; 1978; 13(2):161-7. PubMed ID: 24891 [No Abstract] [Full Text] [Related]
15. [Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation]. Anthonisen P; Bárány F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H Ugeskr Laeger; 1974 Aug; 136(32):1798-802. PubMed ID: 4153180 [No Abstract] [Full Text] [Related]
16. Proceedings: Treatment of ulcerative colitis with disodium cromoglycate: a long-term double-blind clinical trial. Mani V; Lloyd G; Green F; Fox H; Turnberg LA Gut; 1975 Oct; 16(10):832. PubMed ID: 812780 [No Abstract] [Full Text] [Related]
17. [Treatment of ulcerative colitis during the active phase. Clinical study]. Morettini A; Allamani A; Botti P; Innocenti S; Morandi S Minerva Dietol Gastroenterol; 1983; 29(2):117-22. PubMed ID: 6136010 [No Abstract] [Full Text] [Related]
18. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine. Goenka MK; Kochhar R; Tandia B; Mehta SK Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial. Musch E; Andus T; Malek M; Chrissafidou A; Schulz M Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224 [TBL] [Abstract][Full Text] [Related]
20. Long-term study of the effect of treatment for ulcerative colitis. Henrikson B; Hultén L; Filipson S; Sillĕn U Prog Pediatr Surg; 1978; 11():27-39. PubMed ID: 24233 [No Abstract] [Full Text] [Related] [Next] [New Search]